Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
Abstract Diabetic kidney disease (DKD), one of the most prevalent microvascular complications of diabetes, arises from dysregulated glucose and lipid metabolism induced by hyperglycemia, resulting in the deterioration of renal cells such as podocytes and tubular epithelial cells. Programmed cell dea...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10020-024-01020-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846112477945790464 |
|---|---|
| author | Fengzhao Liu Zhenyu Yang Jixin Li Tao Wu Xiangyu Li Lijuan Zhao Wenru Wang Wenfei Yu Guangheng Zhang Yunsheng Xu |
| author_facet | Fengzhao Liu Zhenyu Yang Jixin Li Tao Wu Xiangyu Li Lijuan Zhao Wenru Wang Wenfei Yu Guangheng Zhang Yunsheng Xu |
| author_sort | Fengzhao Liu |
| collection | DOAJ |
| description | Abstract Diabetic kidney disease (DKD), one of the most prevalent microvascular complications of diabetes, arises from dysregulated glucose and lipid metabolism induced by hyperglycemia, resulting in the deterioration of renal cells such as podocytes and tubular epithelial cells. Programmed cell death (PCD), comprising apoptosis, autophagy, ferroptosis, pyroptosis, and necroptosis, represents a spectrum of cell demise processes intricately governed by genetic mechanisms in vivo. Under physiological conditions, PCD facilitates the turnover of cellular populations and serves as a protective mechanism to eliminate impaired podocytes or tubular epithelial cells, thereby preserving renal tissue homeostasis amidst hyperglycemic stress. However, existing research predominantly elucidates individual modes of cell death, neglecting the intricate interplay and mutual modulation observed among various forms of PCD. In this comprehensive review, we delineate the diverse regulatory mechanisms governing PCD and elucidate the intricate crosstalk dynamics among distinct PCD pathways. Furthermore, we review recent advancements in understanding the pathogenesis of PCD and explore their implications in DKD. Additionally, we explore the potential of natural products derived primarily from botanical sources as therapeutic agents, highlighting their multifaceted effects on modulating PCD crosstalk, thereby proposing novel strategies for DKD treatment. |
| format | Article |
| id | doaj-art-3d9b3cf72e0741d2a79800ec5476355f |
| institution | Kabale University |
| issn | 1528-3658 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | BMC |
| record_format | Article |
| series | Molecular Medicine |
| spelling | doaj-art-3d9b3cf72e0741d2a79800ec5476355f2024-12-22T12:32:13ZengBMCMolecular Medicine1528-36582024-12-0130115210.1186/s10020-024-01020-5Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapyFengzhao Liu0Zhenyu Yang1Jixin Li2Tao Wu3Xiangyu Li4Lijuan Zhao5Wenru Wang6Wenfei Yu7Guangheng Zhang8Yunsheng Xu9First College of Clinical Medicine, Shandong University of Traditional Chinese MedicineGraduate School of Heilongjiang University of Chinese MedicineXi Yuan Hospital, China Academy of Chinese Medical SciencesSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineWangjing Hospital, China Academy of Chinese Medical SciencesFirst College of Clinical Medicine, Shandong University of Traditional Chinese MedicineXi Yuan Hospital, China Academy of Chinese Medical SciencesFirst College of Clinical Medicine, Shandong University of Traditional Chinese MedicineFirst College of Clinical Medicine, Shandong University of Traditional Chinese MedicineDepartment of Endocrinology, Second Affiliated Hospital of Shandong University of Traditional Chinese MedicineAbstract Diabetic kidney disease (DKD), one of the most prevalent microvascular complications of diabetes, arises from dysregulated glucose and lipid metabolism induced by hyperglycemia, resulting in the deterioration of renal cells such as podocytes and tubular epithelial cells. Programmed cell death (PCD), comprising apoptosis, autophagy, ferroptosis, pyroptosis, and necroptosis, represents a spectrum of cell demise processes intricately governed by genetic mechanisms in vivo. Under physiological conditions, PCD facilitates the turnover of cellular populations and serves as a protective mechanism to eliminate impaired podocytes or tubular epithelial cells, thereby preserving renal tissue homeostasis amidst hyperglycemic stress. However, existing research predominantly elucidates individual modes of cell death, neglecting the intricate interplay and mutual modulation observed among various forms of PCD. In this comprehensive review, we delineate the diverse regulatory mechanisms governing PCD and elucidate the intricate crosstalk dynamics among distinct PCD pathways. Furthermore, we review recent advancements in understanding the pathogenesis of PCD and explore their implications in DKD. Additionally, we explore the potential of natural products derived primarily from botanical sources as therapeutic agents, highlighting their multifaceted effects on modulating PCD crosstalk, thereby proposing novel strategies for DKD treatment.https://doi.org/10.1186/s10020-024-01020-5Diabetic kidney diseaseProgrammed cell deathNatural productsPodocytesTubular epithelial cells |
| spellingShingle | Fengzhao Liu Zhenyu Yang Jixin Li Tao Wu Xiangyu Li Lijuan Zhao Wenru Wang Wenfei Yu Guangheng Zhang Yunsheng Xu Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy Molecular Medicine Diabetic kidney disease Programmed cell death Natural products Podocytes Tubular epithelial cells |
| title | Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy |
| title_full | Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy |
| title_fullStr | Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy |
| title_full_unstemmed | Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy |
| title_short | Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy |
| title_sort | targeting programmed cell death in diabetic kidney disease from molecular mechanisms to pharmacotherapy |
| topic | Diabetic kidney disease Programmed cell death Natural products Podocytes Tubular epithelial cells |
| url | https://doi.org/10.1186/s10020-024-01020-5 |
| work_keys_str_mv | AT fengzhaoliu targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy AT zhenyuyang targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy AT jixinli targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy AT taowu targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy AT xiangyuli targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy AT lijuanzhao targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy AT wenruwang targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy AT wenfeiyu targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy AT guanghengzhang targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy AT yunshengxu targetingprogrammedcelldeathindiabetickidneydiseasefrommolecularmechanismstopharmacotherapy |